New research on stem cell transplantation for myeloid cancers
from Dana-Farber Cancer Institute via ScienceDaily
Improving outcomes for patients with myeloid cancers who undergo stem cell transplantation is a focus of several studies to be presented by Dana-Farber Cancer Institute scientists at the American Society of Hematology (ASH) Annual Meeting Dec. 1-4. The research points to new opportunities for preventing relapse after transplantation and determining which patients should be considered for lower-intensity chemotherapy in preparation for transplant.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063